BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barnes EL, Jiang Y, Kappelman MD, Long MD, Sandler RS, Kinlaw AC, Herfarth HH. Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis. Inflamm Bowel Dis 2020;26:1225-31. [PMID: 31634390 DOI: 10.1093/ibd/izz247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Olbei M, Thomas JP, Hautefort I, Treveil A, Bohar B, Madgwick M, Gul L, Csabai L, Modos D, Korcsmaros T. CytokineLink: A Cytokine Communication Map to Analyse Immune Responses-Case Studies in Inflammatory Bowel Disease and COVID-19. Cells 2021;10:2242. [PMID: 34571891 DOI: 10.3390/cells10092242] [Reference Citation Analysis]
2 Barnes EL, Raffals L, Long MD, Syal G, Kayal M, Ananthakrishnan A, Cohen B, Pekow J, Deepak P, Colombel JF, Herfarth HH, Sandler RS. Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States. Crohns Colitis 360 2020;2:otaa039. [PMID: 32744536 DOI: 10.1093/crocol/otaa039] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ni A, Al-Qahtani M, Salama E, Marinescu D, Khalil MA, Faria J, Morin N, Ghitulescu G, Vasilevsky CA, Boutros M. Trends in Colectomies for Colorectal Neoplasms in Ulcerative Colitis: a National Inpatient Sample Database Analysis over Two Decades. J Gastrointest Surg 2020;24:1721-8. [PMID: 32557016 DOI: 10.1007/s11605-020-04666-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Barnes EL. Postoperative Crohn's disease management. Curr Opin Gastroenterol 2020;36:277-83. [PMID: 32304384 DOI: 10.1097/MOG.0000000000000638] [Reference Citation Analysis]
5 Hoffmann P, Globig AM, Thomann AK, Grigorian M, Krisam J, Hasselblatt P, Reindl W, Gauss A. Tofacitinib in Treatment-Refractory Moderate to Severe Ulcerative Colitis: Real-World Experience from a Retrospective Multicenter Observational Study. J Clin Med 2020;9:E2177. [PMID: 32664204 DOI: 10.3390/jcm9072177] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Bai L, Scott MKD, Steinberg E, Kalesinskas L, Habtezion A, Shah NH, Khatri P. Computational drug repositioning of atorvastatin for ulcerative colitis. J Am Med Inform Assoc 2021;28:2325-35. [PMID: 34529084 DOI: 10.1093/jamia/ocab165] [Reference Citation Analysis]
7 Rodríguez-Lago I, Barreiro-de Acosta M. The natural history of extraintestinal manifestations after surgery in inflammatory bowel disease: Never give up! United European Gastroenterol J 2021. [PMID: 34432385 DOI: 10.1002/ueg2.12127] [Reference Citation Analysis]
8 Jampala N, Jain A, Herfarth HH, Long MD, Weaver KN, Barnes EL. Personalized Best: Toward Improving Care in Ulcerative Colitis. Dig Dis Sci 2021;66:3736-9. [PMID: 34463883 DOI: 10.1007/s10620-021-07221-w] [Reference Citation Analysis]
9 Luo L, Qing L, Yao C, Liu D, Li Y, Li T, Feng P. Efficacy and safety of hyperbaric oxygen therapy for moderate-to-severe ulcerative colitis: a protocol for a systematic review and meta-analysis. BMJ Open 2021;11:e047543. [PMID: 34183344 DOI: 10.1136/bmjopen-2020-047543] [Reference Citation Analysis]
10 Soriano CR, Powell CR, Chiorean MV, Simianu VV. Role of hospitalization for inflammatory bowel disease in the post-biologic era. World J Clin Cases 2021; 9(26): 7632-7642 [PMID: 34621815 DOI: 10.12998/wjcc.v9.i26.7632] [Reference Citation Analysis]